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Suppressor T  cells (Ts) 1 have been described in many allogeneic systems and 
may play  a  role  in  preventing allograft  rejection in  tolerized  (1-5),  antigen- 
pretreated (6-9), passively enhanced (10,  11), or cyclosporin A-treated (12,  13) 
recipients with long-term surviving transplants. The interactions between the Ts 
and  their  target  cells are  largely undefined.  If Ts  cells were specific for  the 
appropriate  alloantigenic receptor on  antigen-reactive cells,  i.e.,  antiidiotypic, 
they could  react  directly  with  alloreactive  clones  of cells  capable  of causing 
rejection. This form of suppression would be exquisitely specific as only clones 
of alloreactive  cells  bearing  the  appropriate  receptors  would  be  suppressed. 
Although  strictly  allospecific  suppression  has  been  described  (9),  our  recent 
studies  (I 4) show  a  distinct  lack of specificity, particularly in  active allograft 
enhancement models thought to be mediated by Ts. In these models, haplotype- 
specific suppression was able to protect a heterozygous transplant, and suppres- 
sion of responses to major histocompatibility complex (MHC) antigens could be 
induced by pretreatment with minor alloantigens. 
A simple model to explain the apparent lack of specificity is that Ts can effect 
their regulatory functions via an antigen bridge. Thus, if a  Ts is specific for a 
"suppressor determinant" X on a multideterminant antigen expressing epitopes 
X, Y, and Z, the Ts will regulate the response to Y and Z antigens or any other 
determinant  associated  with  the  suppressor  determinant,  X.  Therefore,  the 
specificity of suppression observed in any given system depends on the antigen 
presented to the Ts and not solely on the precise specificity of the Ts itself. In 
this way, Ts  in  DA (RT1 a) rats with specificity for LEW  (RT1 j) antigens will 
prevent rejection of (LEW  ×  BN)  F1  kidneys but not of BN (RTI") allografts 
(14). Similarly, Ts specific for minor antigens can protect allografts across MHC 
barriers if the appropriate minor antigens are expressed on the graft (14). 
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To  extend  this  concept  further,  it  should  be  possible  to  use  an  artificial 
suppressor  determinant  to manipulate  allograft rejection.  In this study we show 
that  Ts  specific  for a  hapten,  trinitrophenyl  (TNP),  can  suppress  kidney  graft 
rejection in recipients  treated with TNP-donor  alloantigens. 
Materials  and  Methods 
Animals.  Rats  of the  DA  (RTP),  LEW (RTll),  PVG/c  (RTV)  inbred  strains  were 
supplied by the Animal Unit of the John  Radcliffe Hospital,  Oxford.  Female rats,  8-20 
wk old, were used throughout. 
Induction  of Suppressor Cells.  Suppressor  cells  were  induced  by treatment  with  the 
nascent, chemically reactive forms of two haptens.  DA rats  were injected intravenously 
with  20 mg of trinitrobenzene  sulphonic acid (TNBS) (Sigma Fine Chemicals,  London) 
or dinitrobenzene sulphonic acid (DNBS) (Eastman Kodak Co., Rochester, NY) dissolved 
in  1 ml saline, and adjusted to pH 8 using 1 M NaOH in saline. 
Preparation of Haptenated Alloantigens.  Spleen  cells  suspensions  from LEW or PVG 
rats were freed of erythrocytes using Gey's hemolytic buffer. The leukocytes were then 
incubated  at  108  cells/ml  in  1  mM  TNBS,  1  mM  DNBS,  or  100  #g/ml  fluorescein 
isothiocyanate (FITC) (Sigma Fine Chemicals) in phosphate-buffered saline for 10 rain at 
37°C.  The cells were washed three  times  using minimal  essential  medium (MEM) with 
5% fetal calf serum (FCS), resuspended at  108 cells/ml in MEM-FCS, ultrasonicated at 20 
kHz on ice (4 x  20 s at  100 W), and centrifuged at 2,000 g for 10 min. The supernatant 
fluid containing the haptenated alloantigenic preparation  was stored in small aliquots at 
-20°C. 
Adoptive Transfer of Cells.  Hapten-activated suppressor cells were assayed by adoptive 
transfer to sublethally irradiated  (I00,  200,  or 400 rad x  ray delivered at  133 rad/min 
through a  1.4 mm copper filter) syngeneic DA rats. Spleen, thymus, and lymph node ceil 
suspensions were prepared 2 d to 12 wk after injection of nascent haptens. The cells were 
washed in  MEM-FCS hut,  except  where stated,  were otherwise  untreated.  Usually,  l08 
cells  (or the  number  of cells  recovered  from a  separation  procedure  starting  with  l08 
cells)  were transferred into each recipient rat. 
Separation of Cells.  The  cell  surface  phenotype  of the  suppressor  cells  was  studied 
using several separation  techniques,  hnmunoglobulin-positive (Ig  +) B cells were depleted 
by panning on plates coated with affinity-purified rabbit anti-rat (RAR) Ig antibody (15). 
The  depleted  cells  were  >98%  Ig-  when  examined  by  FITC-RAR  labeling  and  flow 
cytometry. In some groups the panned  Ig- cells were further fractionated by incubation 
with  either  W3/25  (T helper  cell) or OX8 (T cytotoxic/suppressor cell)  antibody and 
rosetting with sheep erythrocytes coated with anti-rat Ig (16). Nylon wool-adherent cells 
were removed according to the murine method (15). Nylon wool-nonadherent cells were 
~98%  Ig- by FITC-RAR Ig labeling and  ultraviolet  light  microscopy. However, there 
was a  considerable  loss of cells  during  this  procedure.  Routinely,  23-36%  of the  cells 
applied to the nylon wool column elute in the nonadherent fraction, compared with the 
46-52% of cells in the DA spleen  that are Ig- or Ia- (Hutchinson,  unpublished results). 
Hence, one-third to one-half of the Ig- cells were lost at this stage. In another experiment, 
putative suppressor cells were incubated at 20°C for 30 min in a  l:100 dilution of W3/ 
13 pan T  cell monoclonal ascites exudate antibody (Sera Labs, Crawley, UK) at 10  s cells/ 
ml, followed by the addition  of an equal  volume of rabbit complement diluted  1:5 and 
incubation for 60 min at 37°C. 
Drugs and Irradiation of CeUs.  Cyclophosphamide (Farmitalia Carlo Erba Ltd., Barnet, 
England)  was given intraperitoneally  at  a  dose of 50 mg/kg; cortisone (Cortistab;  The 
Boots Company plc,  Nottingham,  England)  was given  intraperitoneally  at  100  mg/kg. 
Cells were irradiated with  1,000 rad gamma rays from a cesium 137 source (Gamma Cell 
1000; Atomic Energy of Canada, Ltd., Ottawa) at a rate of 450 rad/min. 
Kidney Transplantation.  The left kidney of DA recipients was removed and replaced 
with a  kidney from LEW or PVG donors,  using end-to-end anastomoses of artery, vein, 
and  ureter.  The  operation  was  performed  under  ether/chloral  anesthesia  and  warm HUTCHINSON,  BARBER,  AND  MORRIS  1411 
ischemia  was  generally  20-30  min.  1  wk  after  transplantation,  the  recipient's  own 
remaining  (right)  kidney was removed so that,  from  then  on,  survival  of the rat  was 
dependent on graft function. This delayed contralateral nephrectomy model prevents the 
occasional  long-term  survival  of untreated  recipients  due to  uremia-induced  immuno- 
suppression  in the first week, and enables inspection  of the transplant on day 7. 
Experimental Protocol.  Recipient DA rats  were irradiated  2 d before transplant  and 
received 10  s suppressor cells and hapten-modified alloantigen  derived from  107 spleen 
cells the day before transplantation. 
Results 
Suppression  of AUograft Rejection by TNBS-induced  Suppressor Cells.  Adoptive 
transfer of normal  DA spleen cells to 400-rad-irradiated  syngeneic rats  either 
with or without TNP-LEW antigen (Table I, groups $2 and S1, respectively) did 
not cause long-term survival of subsequent LEW renal allografts. However, when 
spleen cells from TNBS-pretreated  rats were transferred  with TNP-LEW anti- 
gen,  the  majority of recipients  survived  for >100  d  (Table  I,  groups  $4-$8). 
Pooling all  data  (group  $4), it can  be seen that,  of 43  rats,  34 (79%) survived 
>100 d and 37 (86%) for >50 d. 
Appearance  of Suppressor Cells in Spleen,  Thymus, and Lymph Nodes after TNBS 
Treatment.  The time course of the appearance of suppressor cells differed from 
one lymphoid compartment to another.  There were effective suppressor cells in 
the spleen within  2 d  of TNBS injection (Table I, group $5) and they were still 
present  12 wk after activation. We have routinely transferred splenic suppressor 
cells from rats pretreated with TNBS 7-21  d previously (Table I, groups $6-$8 
and  Tables  II-V).  By contrast,  the  most effective suppression  with  thymus or 
lymph nodes cells was observed at 2 wk postinduction (Table I, groups T5 and 
LN5), and this was particularly evident in the case of lymph node cells. 
Radiation  Dependence of Adoptive Transfer of Suppression.  There was a require- 
ment  for  sublethal  irradiation  for  the  adoptive  cell  transfer.  Rats  routinely 
received 400 rad but 200 would suffice (group S10), while rats given either  100 
rad  (group  S12)  or  no  irradiation  (group  S14)  did  not accept the  subsequent 
allografts. 
Cell Surface  Phenotype of the Splenic Suppressor  Cells.  Spleen  cells from  DA 
rats pretreated  with TNBS 7-21  d  previously were fractionated and tested for 
suppressor cell activity. Removal of Ig  + cells by panning on anti-Ig plates did not 
deplete suppressive activity (Table II, group 5) whereas removal of T  cells with 
the pan T  cell antibody W3/13 and complement did (group 8). Fractionation by 
rosetting to remove W3/25 + cells failed to abrogate suppressive activity (group 
6).  We conclude  that  the  cell  responsible  for  suppression  is  an  OX8 + T  cell, 
although,  strictly,  it is a  Ig-,  W3/25- cell. The suppressor cell was adherent  to 
nylon wool (group 9), a  charateristic  that  has been reported  for populations of 
activated Ts cells in the mouse (18,  19). 
Drug and Radiation  Sensitivity of TNBS-activated  Suppressor Cells.  Spleen cells 
from rats given TNBS  14 d  before transfer and 50 mg/kg cyclophosphamide 2 
d  before  transfer  were  not  suppressive  (Table  III,  group  3)  indicating  their 
sensitivity to this drug.  Similarly, irradiation  with  1,000 rad gamma rays imme- 
diately before transfer abrogated the suppressor activity of either spleen cells or 
thymus cells (both  7  d  after TNBS) (Table  III,  groups  5  and  9,  respectively). 1412  SUPPRESSION  OF  ALLOGRAFT  REJECTION  BY  TNP-SPECIFIC  Ts 
TABLE  I 
Suppression of LEW to DA Kidney Allografi  Rejection by Spleen, Thymus, and Lymph Node 
Cells from Normal or TNBS-treated  DA Rats 
Group  diation*X  Ra-  CellSferred  ~trans-  Antigen  §  n II  Survival  ~  MST**  P~ 
rad 
CI  400  Nolle 
C2  400  None 
S1  400  Normal spleen 
$2  400  Normal spleen 
$3  400  TNBS spleen 
(7-21) 
$4  400  TNBS spleen 
(2-84) 
$5  400  TNBS spleen (2) 
$6  400  TNBS spleen (9) 
$7  400  TNBS spleen 
(14-16) 
$8  400  TNBS spleen 
(19-21) 
$9  200  Normal spleen 
S10  200  TNBS spleen 
(7-21) 
SI 1  100  Normal spleen 
S 12  100  TN BS spleen 
(7-21) 
S 13  None  Normal spleen 
S14  None  TNBS spleen 
(7-21) 
TI  400  Normal thymus 
T2  400  Normal thymus 
T3  400  TNBS thymus 
(9) 
T4  400  TNBS thymus 
(6-7) 
T5  400  TNBS thymus 
(14-16) 
T6  400  TNBS thymus 
(19-22) 
I.N 1  400  Normal LN 
1.N2  400  Normal LN 
LN3  400  TNBS LN (9) 
LN4  400  TNBS LN (7-9) 
LN5  400  TNBS LN (14- 
16) 
d 
None  5  10, 10,  11, 11,  11  11 
TNP-LEW  5  11,12,12,14,22  12 
None  5  10,  10,  11,  11, 16  11 
TNP-LEW  5  11,  16,  17,  17, 18  17 
None  5  10, 10,  10,  12,  14  10 
TNP-LEW  43  14, 16,  17,  19, 27,  >100 
35, 35, 55, 63, 
>I 00 (×34) 
TNP-LEW  5  27,>100(×4)  >100 
TNP-LEW  5  17, >100 (×4)  >100 
TNP-LEW  7  19, 55, 63, >100  >100 
(X4) 
TNP-LEW  4  >100(x4)  >100 
TNP-LEW  5  10,  11,  12,  12, 13  12 
TNP-LEW  6  15, >100 (x5)  >100 
TNP-LEW  6  10, 10,  10,  11,  11, 13  10 
TNP-LEW  4  10,  11,  14, >100  12 
TNP-LEW  5  10,  10,  10,  10, 11  10 
TNP-LEW  5  10,  10,  10,  11, 11  10 
None  5  10,  11,  12,  15, 21  12 
TNP-LEW  7  10, I1,  12,  14, 14,  14 
16, 20 
None  4  11,  13,  14, 18  13 
TNP-LEW  5  19, 32, 42, 50, >100  42 
TNP-LEW  6  14, 41, >100 (x4)  >100 
TNP-LEW  6  20, 21, 23, 25,>100  24 
(x2) 
None  5  14, 14,  15,  16,  18  15 
TNP-LEW  5  12,  13,  14,  15, 22  14 
None  4  12, 13,  16, 17  14 
TNP-LEW  3  10, 14,  16  14 
TNP-LEW  7  12,  18, >100 (x5)  >100 
<0.001 
<0.001 
<0.02 
<0.001 
<0.001 
<0.001 
<0.005 
<0.005 
<0.005 
<0.05 HUTCHINSON,  BARBER,  AND  MORRIS 
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Group  x Ra-  Cells trans-  Antigen  ~  n !  Survival  ~  MST**  P~ 
diation *  ferred  * 
rad  d 
LN6  400  TNBSLN(19-  TNP-LEW  7  10,11,  11,  13,>100  13 
22)  (x3) 
* DA rats were sublethally irradiated with  100, 200, or 400 tad x rays (except groups $13 and 14) 
1 d before adoptive cell transfer. 
* Cell suspensions were prepared from the spleens, thymuses, or lymph nodes of normal or TNBS- 
pretreated  DA  rats.  10 s  cells were  transferred  to  each  recipient.  The  number  in  parenthesis 
indicates how many days previously the cell donors had been pretreated with TNBS. 
§ Antigen, prepared from 107 TNP-haptenated LEW spleen leukocytes by sonication, were injected 
intravenously at the same time as the cell inoculum. 
II Number in group. 
The day after adoptive cell transfer each rat received a kidney allograft from LEW strain donors. 
The survival of individuals (in days) after transplant is given. 
** Median survival time. 
** Statistical significance of difference between groups $2 and $3-14, group T2 and groups T3-6, 
and group LN2 and groups LN3-6, using the Mann-Whitney U test. 
TABLE  II 
Cell Surface Phenotype of TNBS-activated Spleen Cells that Suppress Rejection of LEW Kidney 
Grafts by DA Rats Treated with TNP-Donor Antigen 
Group  Cells transferred*  Antigen*  n*  Survival (days)*  MST*  P~ 
1  Normal unfractionated  TNP-LEW  5  11,  16,  17,  17,  18  17  -- 
2  Normal panned T  cells  TNP-LEW  5  11,  17,  19, 20, 35  19  NS 
3  Normal OX8 + T  cells  None  5  11, 12,  12,  14,  18  12  NS 
4  TNBS unfractionated  TNP-LEW 
5  TNBS Ig- T  cells  TNP-LEW 
6  TNBS W3/25- T  cells  TNP-EEW 
(OX8) 
7  TNBS +  C  TNP-LEW 
8  TNBS +  W3/13 +  C  TNP-LEW 
9  TNBS nylon wool nonad-  TNP-LEW 
herent 
16  17,  19, 55, 63,  >100  <0.001 
>100 (×12) 
5  >100 (×5)  >100  <0.001 
5  33,>100 (X4)  >100  <:0.001 
6  >100 (×6)  >100  <0.001 
5  10,  14,  19, 20, 23  19  NS 
4  14,  17, 25, >50  21  NS 
* Spleen cells from normal or TNBS-treated DA rats were fractionated before adoptive transfer to 
400-rad-irradiated syngeneic recipients. Fractionation procedures were: panning on anti-Ig plates, 
rosetting to remove W3/25 + cells, treatment with rabbit complement or with W3/13 antibody and 
complement, or nylon wool adherence (see text). 
* See footnotes to Table I. 
§ Statistical significance compared with group 1 using the Mann-Whitney U test. NS, not significant. 
Finally, the Ts cells were shown  to be cortisone  resistant.  Thymus  cells from  rats 
given  TNBS  2  wk before  transfer  and  100  mg/kg  cortisone  2  d  before  transfer 
were  still able to prolong  renal  allograft  survival (Table  III, group  8). 
AUospec~city  of  Suppression  Mediated  by  TNBS-activated  Suppressor  Cells. 
According  to  our  hypothesis  that  suppression  in  this  system  is  mediated  by  an 
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TABLE  III 
Drug and Radiation Sensitivity of TNBS-activated  Spleen Suppressor Cells Transferred to DA 
Recipients Using LEW Kidneys 
Group  Cells transferred*  Antigen*  n*  Survival (days)*  MST*  P~ 
1  Normal spleen  TNP-LEW  5  11, 16,  17,  17,  18  17 
2  TNBS spleen  TNP-LEW  7  19, 55, 63, >100 (×4)  >100  <0.001 
3  Cy TNBS spleen  TNP-LEW  4  11,  15,  16,  17  15  NS 
4  TNBS spleen  TNP-LEW  5  17, >100 (X4)  >100  0.016 
5  1,000 tad TNBS spleen  TNP-LEW  7  12, 12,  14,  15,  17, 19  14  NS 
6  Normal thymus  TNP-LEW  7  10, 11,  12, 14,  14, 16, 20  14  NS 
7  TNBS thymus  TNP-LEW  5  19, 32, 42, >100 (X2)  42  0.003 
8  HCTNBSthymus  TNP-LEW  4  24,>100(x3)  >100  <0.001 
9  1,000radTNBSthymus  TNP-LEW  5  10,  13,  13, 20, 27  13  NS 
* Spleen or thymus cells from DA rats treated with TNBS 14 d previously were adoptively transferred 
after either drug treatment of the cell donors or irradiation of the cells immediately before transfer. 
In group 3, cell donors received 50 mg/kg cyclophosphamide (Cy) 2 d before spleen cell transfer. 
in group 8, cell donors were given 100 mg/kg hydrocortisone (HC) 2 d before thymus cell transfer. 
In groups 5 and 8, cells were irradiated with 1,000 rad gamma rays before transfer. 
* See footnotes to Table I. 
§ Statistical significance comparing groups 2-5 with group 1, and 7-9 with group 6, using the Mann- 
Whitney U test. NS, not significant. 
TABLE  IV 
Allospecificity of Suppression Mediated  by TNBS-activated  Splenic Suppressor  Cells 
Transferred to DA Recipients before Receiving a LEW or PVG Kidney 
Group  Ceils*  Antigen*  Kidney  §  n II  Survival (days) 1  MST**  P** 
1  TNBS  TNP-LEW  LEW  16  17,  19, >50 (x14)  >50  <0.001 
2  TNBS  TNP-PVG  LEW  5  11,  15,  17, 20, 28  17 
3  TNBS  TNP-LEW  PVG  5  11, 15,  17,  17, 20  20  <0.005 
4  TNBS  TNP-PVG  PVG  8  16, 22, 46, >50  >50 
(x5) 
* Spleen cells from DA rats pretreated with TNBS 7-21 d beforehand were adoptively transferred 
into 400-rad-irradiated syngeneic recipients. 
* TNP-haptenated antigens, prepared from either LEW or PVG spleen leukocytes, were injected 
with the cell inoculum. 
The day after adoptive cell transfer, recipient rats were given a LEW or PVG renal allograft. 
u Number in group. 
I Individual survival times in days. 
** Median survival time. 
** Statistical  significance of the comparisons between groups  1 and 2 or 3 and 4 using the Mann- 
Whitney U test. 
on the  bridging  antigen.  Hence  TNP-specific  cells will protect  LEW  kidneys in 
rats treated with TNP-LEW  but not TNP-PVG  (third-party) alloantigen, whereas 
rats  given  TNBS-activated  spleen  cells  and  TNP-PVG  antigen  rejected  LEW 
kidneys (Table  IV, group  2).  In the reciprocal  groups,  rats given TNP-induced 
suppressor cells and TNP-PVG  antigen retained a  PVG  kidney (Table IV, group 
4) but those given TNP-LEW  antigen were responsive to PVG antigens, rejecting 
the PVG  kidney (group  3). 
Haptenic Specificity of TNBS-induced  Suppressor Cells.  The  argument  that  the 
specificity of suppression  will depend  on epitopes on the antigen  bridge  applies Haptenic 
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TABLE  V 
Spec~city of Suppression Mediated by Hapten-activated Suppressor Cells Transferred 
to DA Recipients  Treated with Hapten-conjugated Donor Alloantigen before 
Receiving LEW Kidneys. 
Group 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Cells*  Antigen*  n  §  Survival (days)  §  MST  §  P! 
None  None  5  10,  10,  11,  ll, 11  ll 
None  DNP-LEW  5  10,  13,  15,  19, 21  15 
None  TNP-LEW  5  11,  12,  12,  14,22  12 
None  FITC-LEW  3  12,  14,  18  14 
Normal  None  5  10,  10,  11,  11,  16  11  NS 
Normal  DNP-LEW  5  12,  13,  14,  18, 20  14  NS 
Normal  TNP-LEW  5  11,  16,  17,  17,  18  17  NS 
Normal  FITC-LEW  4  11,  13,  17,  17  15  NS 
DNBS  None  6  11,  13,  14,  14,  17,  17  14  NS 
DNBS  DNP-LEW  7  14, 27, >100 (×5)  >100  <0.02 
DNBS  TNP-LEW  7  10,  14,  15, 17, 21,  17  NS 
>100 (x2) 
12  TNBS  None  5  10,  10,  10,  12,  14  10  NS 
13  TNBS  DNP-LEW  7  1 t, >100 (x6)  >100  <0.02 
14  TNBS  TNP-LEW  16  17,  19, 55, 63, >100  >100  <0.001 
(x12) 
15  TNBS  FITC-LEW  5  10,  11,  13,  14,  18  13  NS 
16  TNBS  LEW  5  10,  11,  14, 22, >50  14  NS 
17  TNBS  TNP-PVG+LEW  5  10,  19, 45, >100 (×2)  45  NS 
* Spleen cells from DA rats treated with DNBS or TNBS (see text). 
* LEW  spleen  cell  antigen,  either  umnodified  (group  16)  or  haptenated  with  DNP,  TNP,  or 
fluorescein (FITC), was injected intravenously at the time of adoptive cell transfer. 
§ See footnotes to Table I. 
u Statistical significance of difference between groups 1 and 5, 9, and  12; groups 2 and 6,  10, and 
13; groups 3 and 7,  11,  14, and 17; and groups 4 and 8 and 15. NS, not significant. 
equally to the suppressor cell and the target of suppression. Thus, TNP-specific 
suppressors  should  suppress  alloreactive  cells  only  in  the  presence  of TNP- 
haptenated alloantigens. 
We  have  tested  dinitrophenyl  (DNP)-  and  TNP-activated  suppressor  cells 
transferred with DNP-, TNP-, or FlTC-haptenated alloantigens in this kidney 
allograft model. TNBS-activated cells suppressed graft rejection in rats treated 
with DNP- or TNP-modified alloantigens (Table V, groups  13 and  14) but not 
in rats given FITC-haptenated or unmodified antigen (Table V, groups  15 and 
16). DNBS-activated Ts suppressed rejection of grafts in rats given DNP-hapten- 
ated alloantigen (group 10) but there was only a weak crossreaction with TNP- 
haptenated donor antigen in this direction, and five of seven rats given DNP-Ts 
and TNP-a|loantigen rejected their grafts (group  11).  We have found that, for 
effective suppression, the hapten and the alloantigen have to be covalently linked. 
A  mixture  of  unmodified  LEW  antigen  and  TNP-haptenated  PVG  antigen 
induced long-term survival of only two of five LEW  kidneys (Table V,  group 
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Discussion 
The ability of helper T  cells specific for one epitope on a  multi-determinant 
antigen  to  help  the  response  to another  epitope has  long been accepted.  The 
classic example  is the  hapten-carrier  effect in  B cell activation  (20).  It is clear 
that similar interactions  occur in the activation of T  cells and that the epitopes 
need not be on the same molecule. For instance, in the in vitro mixed lymphocyte 
reaction,  class  II  MHC  antigen-specific  T  helper  cells  can  play  a  role  in  the 
activation  of cytotoxic T  lymphocytes specific for class I  MHC antigens on the 
surface of stimulator cells expressing both class I and II products (21). Suppres- 
sion, too, can be mediated via an antigen bridge so that suppressor cells specific 
for one epitope can suppress responses to another. This has been shown for both 
B and T  cell responses to hen egg lysozyme (22) and other antigens (23, 24), and 
may represent an important component in immune regulation. 
We wished to examine suppression of T  cell responses via antigen  bridges in 
allogeneic systems. Suppression of delayed-type hypersensitivity (DTH) to MHC 
antigens (25) and allograft rejection (14) can be brought about by pretreatment 
with  minor  alloantigens,  an  effect probably mediated  by Ts specific for these 
minor allodeterminants.  The complexity of such systems makes detailed analyses 
difficult,  especially  as  minor  transplantation  antigen  systems  have  not  been 
extensively characterized in species other than the mouse. 
Studies in  mice have shown that  DTH responses to the hapten  TNP can be 
suppressed by T  cells from TNP-tolerant animals (26). TNP is a small, chemically 
defined  molecule  that  can  be covalently coupled  with  ease  to  transplantation 
antigens without destroying alloantigenic activity (27). The biochemistry of this 
reaction is well documented and TNP-coupled antigens have been used in studies 
of cytotoxic  T  lymphocyte  activation  (28,  29).  In  addition,  the  suppression 
mediated by TNP-activated Ts in DTH models has been extensively studied in 
mice (30,  31).  We have shown that  suppression of hapten-specific DTH in  the 
rat is more pronounced than  it is in the mouse. ~ Thus we chose to use a  model 
system in which TNP-specific suppressor cells were used, in combined treatment 
with TNP-alloantigen,  to suppress rat renal allograft rejection. 
Spleen cells from TNBS-treated DA rats do protect LEW kidneys in recipients 
treated with TNP-LEW antigen  (Table I, group $4). They appear in the spleen 
within  2  d  of TNBS injection  and persist for up to  12 wk.  However, they are 
sensitive to both cyclophosphamide and radiation  (Table III,  groups  3 and  5), 
which may indicate  that  they have to divide in response to TNP-alloantigen  in 
the adoptive cell transfer recipient to exert their suppressive influence. 
Suppressor cells are to be found in the thymus and lymph nodes after TNBS 
injection but their appearance is relatively transient,  especially in lymph nodes, 
when  compared  with  the  spleen  (Table  I,  groups  T4-T6  and  LN4-6).  The 
thymocytes are a  mature subpopulation, in being cortisone resistant (Table III, 
group 8), and their function, like that of splenocytes, is radiation sensitive (Table 
III,  group 9).  The distribution  and kinetics of appearance of these suppressors 
indicates that they belong to the mature,  sessile, spleen-seeking T1  category of 
T  cells (32), and are activated in situ. The transient appearance in lymph nodes 
2 Prop, J.,  A. G. Griffiths, I.  V. Hutchinson, and P. J.  Morris. Specific suppressor T  cells in rats 
active in the afferent phase of contact sensitivity. Submitted for publication. HUTCHINSON,  BARBER,  AND  MORRIS  1417 
may, however, reflect a different balance of help and suppression compared with 
the spleen rather than a quirk in recirculation potential. We have not examined 
the phenotype of lymph node suppressor populations. 
The cell surface phenotype of spleen cell populations  was examined in  the 
period 7-21  d after TNBS injection, and it would appear that the suppression is 
mediated by T  cells.  Removal of Ig  + cells by panning did not adversely affect 
suppressor function (Table II, group 5), whereas removal of T  cells did (Table 
I1, group 8).  Nor did removal of W3/25 + cells abrogate suppression (Table II, 
group 6).  We have evidence from other systems that the initial activation of Ts 
requires help (14).  The observation that  W3/25-depleted T  cells (presumably 
therefore OX8 + cells) suppress  in  this  system suggests  that  they do  not  need 
TNP-primed help after adoptive transfer, although W3/25 + cells in the recipient, 
perhaps  activated  by  subsequent  allografting,  may be  necessary.  The  T  cell 
nature of the suppressor cells is supported by the finding that  they carry the 
W3/13  pan T  cell marker. Parenthetically, the W3/13  monoclonal antibody is 
of the mouse IgG1  subclass, which poorly fixes complement. However, in high 
concentration and  with  rabbit  complement (which  contains  heterophile  anti- 
bodies),  a  subpopulation  of W3/13 + cells  is  lysed.  The  interpretation  of this 
finding is complicated by the reported presence of the W3/13 antigen on some 
plasma cells (33). 
The adherence of the suppressor cells to nylon wool is in accord with previous 
reports of activated Ts cells in the mouse (18,  19). The nylon wool method was 
originally developed for murine cell fractionation (I 7). When used with rat cells 
under conditions that deplete B cells, there is also a considerable loss of T  cells 
(see Materials and Methods). Normal nonadherent splenocytes respond well in 
mixed  leukocyte  response  assays  (Hutchinson,  unpublished  results)  and  Ig- 
suppressor cells from long-surviving, passively enhanced renal allograft recipients 
are not nylon wool adherent (11).  By contrast, these TNP-activated suppressor 
cells are like the Ts cells described in some other allogeneic (18, 34) and hapten- 
specific (! 9) systems, in that they appear to be nylon wool adherent. 
Our conclusion, then, is that the suppressor ceils in this system are idiotype 
(TNP)-specific, activated OX8 + T cells which need to divide to exert their effects 
and which proliferate in the absence of TNP-primed W3/25 + helper T  cells. 
The  mechanism whereby TNP-specific  Ts  can  suppress  allograft  rejection 
remains a  matter for speculation.  The "antigen bridge" concept is an obvious 
oversimplification and we have begun studies into the details of the suppressive 
cell interactions. The first question is whether these cells produce soluble factors, 
and our preliminary studies suggest that they do. Supernatants from overnight 
cultures of TNBS-activated spleen cells restimulated with TNP-haptenated syn- 
geneic cells are suppressive in vivo preventing rejection of LEW kidneys in DA 
rats treated with TNP-LEW alloantigen. Although we have not yet tested the 
factor alone, it is unlikely to act nonspecifically because LEW kidneys are not 
protected by factor plus TNP-PVG (third party) alloantigen. Other preliminary 
results suggest that the factor is a glycoprotein that may bind antigen. Suppressive 
activity is found in fractions of molecular weight <100,000,  in agreement with 
our conclusion that suppression is mediated by T  cells rather than antibodies. 
Our working hypothesis is that this suppression acts at the level of the antigen- 1418  SUPPRESSION OF  AI.LOGRAFT REJECTION BY TNP-SPECIFIC Ts 
presenting cell, preventing activation of T  helper cells necessary for the rejection 
response. This idea fits with our findings in a rat DTH model that these cells act 
in the afferent rather than efferent phase. 2 
In other systems, Ts cells can be placed in various steps of a rather  complex 
pathway (35,  36).  It is proposed that  a  factor (TsF1) produced by an  idiotype- 
positive cell (Tsl) activates an antiidiotypic (Ts2) cell which, in turn,  elaborates 
a  factor  (TsF2).  This  factor activates  idiotype-positive Ts3  cells to  produce  a 
nonspecifically acting TsF3.  The  TNP-activated  Ts described in  this  paper  fit 
the Tsl  category. However, our current hypothesis is that Ts3 cells are simply 
differentiated Tsl  cells, a  process blocked by irradiation  or cyclophosphamide 
and augmented by antiidiotypic Ts2 cells. We have some evidence derived from 
allogeneic systems to support this view, which will be presented separately. 
Finally, the question arises as to how the transient  influence of TNP-Ts and 
TNP-donor  alloantigen  can  cause  indefinite  survival  of allografts.  Adoptive 
transfer assays show that these long-term survivors have allospecific Ts in their 
spleens and residing in their transplants. 3 These are activated by the transplant; 
perhaps  any  treatment  that  temporarily  interferes  with  helper  cell  activation, 
including  active  or  passive  enhancement  and  treatment  with  donor-specific 
complexes  or  with  cyclosporine,  will  allow  ascendency  of the  suppressor  cell 
population. 
Summary 
Suppressor T  cells, activated by injection of trinitrobenzene  sulphonic acid in 
DA rats, prevented rejection of LEW kidney allografts in a donor-specific manner 
when adoptively transferred into syngeneic recipients along with trinitrophenyl 
(TNP)-haptenated  LEW  alloantigen.  TNP-haptenated  third-party  alloantigen 
was ineffective in  this  system.  The  donor-specific suppression  was dependent, 
too,  on  the  haptenic  portion  of the  chemically  modified  alloantigen.  Hence, 
fluorescein  isothiocyanate-donor  antigen  did  not  lead  to  suppression  in  the 
presence of TNP-reactive suppressor cells. There is, however, some crossreaction 
between DNP- and TNP-haptenated alloantigens so that TNP-reactive cells and 
DNP-donor antigen suppressed rejection whereas DNP-reactive cells and TNP- 
donor antigen did not prevent graft rejection. The suppressor cells were sensitive 
to cyclophosphamide and radiation  but were resistant to hydrocortisone.  They 
appear to be T  cells of the OX8 (suppressor/cytotoxic) phenotype since they are 
positive for the pan T  cell antigen W3/13, are Ig negative, and do not carry the 
W3/25 (T helper cell) marker.  However, these suppressor cells are adherent  to 
nylon wool. They are found mainly in the spleen, are detected there within 2 d 
of TNBS injection, and can persist for up to  12 wk. We propose that these cells 
are  first-order  T  suppressor  (Tsl)  cells  that  act  in  the  afferent  phase  of the 
response to a renal allograft. 
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